Norden Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-32,820
Closed -$351K 636
2025
Q3
$351K Buy
32,820
+17,386
+113% +$171K 0.04% 435
2025
Q2
$149K Sell
15,434
-4,795
-24% -$49.5K 0.02% 546
2025
Q1
$301K Sell
20,229
-331
-2% -$5.09K 0.03% 426
2024
Q4
$307K Buy
+20,560
New +$335K 0.03% 414

Other funds holding OGN

Norden Group's OGN Position: Q4 2025 in Review

Norden Group sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 32,820 shares — an estimated $351K sold.

Norden Group first reported a position in OGN in Q4 2024 and held it in 4 quarters. The position peaked at $351K in Q3 2025. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Norden Group reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Norden Group sold 32,820 Organon & Co shares in Q4 2025, an estimated $351K.
  • Norden Group first reported a position in Organon & Co in Q4 2024 and held it in 4 quarters.
  • Norden Group's Organon & Co position peaked at $351K in Q3 2025.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Norden Group's 13F filing for Q4 2025, filed 13 Jan 2026.